Chronic Lymphocytic Leukemia Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

How to help maintain the mental well-being of CLL patients
Barbara Eichhorst, MD of the University of Cologne, Cologne, Germany, how to take care of the mental well-being of chronic lymphocytic leukemia (CLL) patients. For patients in the wach-and-wait period... Author: VJHemOnc Added: 11/11/2016 (Source: Oncology Tube)
Source: Oncology Tube - November 11, 2016 Category: Cancer & Oncology Source Type: podcasts

The road to individualized treatment for CLL
Stephan Stilgenbauer, MD, PhD of Ulm University, Ulm, Germany, talks about individualized treatment and delivering the right treatment for the right patient in chronic lymphocytic leukemia (CLL). Prof... Author: VJHemOnc Added: 11/04/2016 (Source: Oncology Tube)
Source: Oncology Tube - November 4, 2016 Category: Cancer & Oncology Source Type: podcasts

What we can learn about treating CLL from research on other cancers
Barbara Eichhorst, MD of the University of Cologne, Cologne, Germany, discusses how sharing data between groups on cancer can help a progression in the treatment of chronic lymphocytic leukemia (CLL).... Author: VJHemOnc Added: 11/04/2016 (Source: Oncology Tube)
Source: Oncology Tube - November 4, 2016 Category: Cancer & Oncology Source Type: podcasts

Overcoming mental health issues for patients with CLL
Arnon Kater, MD, PhD of the Academic Medical Center, Amsterdam, Netherlands talks about how to overcome mental health issues that may be seen within chronic lymphocytic leukemia (CLL) patients at the ... Author: VJHemOnc Added: 11/04/2016 (Source: Oncology Tube)
Source: Oncology Tube - November 4, 2016 Category: Cancer & Oncology Source Type: podcasts

From chemotherapy towards targeted therapies in CLL
Jennifer Woyach, MD of The Ohio State University Comprehensive Cancer Center, Columbus, OH talks developments in chronic lymphocytic leukaemia (CLL) at the 2016 International Workshop of the German CL... Author: VJHemOnc Added: 11/03/2016 (Source: Oncology Tube)
Source: Oncology Tube - November 3, 2016 Category: Cancer & Oncology Source Type: podcasts

Importance of taking into consideration new and traditional treatment options for CLL patients
Federico Caligris-Cappio, MD of Universit Vita-Salute San Raffaele, Milan, Italy, talks about new treatment and traditional treatment options for chronic lymphocytic leukemia (CLL) at the 2016 Intern... Author: VJHemOnc Added: 11/03/2016 (Source: Oncology Tube)
Source: Oncology Tube - November 3, 2016 Category: Cancer & Oncology Source Type: podcasts

How clinicans should to talk to CLL patients about their hope and expectations
Arnon Kater, MD, PhD of the Academic Medical Center, Amsterdam, Netherlands talks about how he thinks clinicians should talk to chronic lymphocytic leukemia (CLL) patients about their hopes and expect... Author: VJHemOnc Added: 11/03/2016 (Source: Oncology Tube)
Source: Oncology Tube - November 3, 2016 Category: Cancer & Oncology Source Type: podcasts

Guidance on how to prevent infections in patients with CLL
Carsten Niemann, MD, PhD of Rigshospitalet, Copenhagen, Denmark, provides brief guidance on preventing infections in chronic lymphocytic leukemia (CLL) patients. During neutropenia due to treatment, p... Author: VJHemOnc Added: 11/03/2016 (Source: Oncology Tube)
Source: Oncology Tube - November 3, 2016 Category: Cancer & Oncology Source Type: podcasts

Selinexor for CLL - mechanism of action and combination with ibrutinib
Jennifer Woyach, MD of The Ohio State University Comprehensive Cancer Center, Columbus, OH talks about selinexor for chronic lymphocytic leukaemia (CLL) at the 2016 International Workshop of the Germa... Author: VJHemOnc Added: 11/03/2016 (Source: Oncology Tube)
Source: Oncology Tube - November 3, 2016 Category: Cancer & Oncology Source Type: podcasts

Addressing the issue of cost of treatment in CLL
Stephan Stilgenbauer, MD, PhD of Ulm University, Ulm, Germany, discusses the cost of treatment and collaborations in chronic lymphocytic leukemia (CLL). Novel drugs are of great benefit but they come ... Author: VJHemOnc Added: 11/03/2016 (Source: Oncology Tube)
Source: Oncology Tube - November 3, 2016 Category: Cancer & Oncology Source Type: podcasts

What we are learning about CLL treatments and the microenvironment
Carsten Niemann, MD, PhD of Rigshospitalet, Copenhagen, Denmark, provides an overview of what we are learning about chronic lymphocytic leukemia (CLL) treatments and the microenvironment. During treat... Author: VJHemOnc Added: 11/03/2016 (Source: Oncology Tube)
Source: Oncology Tube - November 3, 2016 Category: Cancer & Oncology Source Type: podcasts

Updates to the iwCLL guidelines
Michael Hallek, MD, PhD of the University of Cologne, Cologne, Germany talks about new International Workshop on Chronic Lymphocytic Leukemia (iwCLL) guidelines at the 2016 International Workshop of t... Author: VJHemOnc Added: 11/03/2016 (Source: Oncology Tube)
Source: Oncology Tube - November 3, 2016 Category: Cancer & Oncology Source Type: podcasts

The use of CLL-IPI, a new prognostic index for CLL
Jasmin Bahlo, PhD of University of Cologne, Cologne, Germany gives an overview CLL-IPI and its use in chronic lymphocytic leukemia (CLL) at the 2016 International Workshop of the German CLL Study Grou... Author: VJHemOnc Added: 11/03/2016 (Source: Oncology Tube)
Source: Oncology Tube - November 3, 2016 Category: Cancer & Oncology Source Type: podcasts

Challenges in CLL - Richter's transformation and acute leukemia
Michael Keating, MD, BS of MD Anderson Cancer Center, Houston, TX discusses challenges in chronic lymphocytic leukemia (CLL) at the 2016 International Workshop of the German CLL Study Group (GCLLSG) h... Author: VJHemOnc Added: 11/03/2016 (Source: Oncology Tube)
Source: Oncology Tube - November 3, 2016 Category: Cancer & Oncology Source Type: podcasts

New CLL treatments, the standard of care and the importance of clonal evolution
Michael Hallek, MD, PhD of the University of Cologne, Cologne, Germany discusses new chronic lymphocytic leukemia (CLL) treatments and FCR (fludarabine, cyclophosphamide, and rituximab) at the 2016 In... Author: VJHemOnc Added: 11/03/2016 (Source: Oncology Tube)
Source: Oncology Tube - November 3, 2016 Category: Cancer & Oncology Source Type: podcasts